TissGDB
Tissglogo

Home

Download

 Statistics

 Landscape

Help

Contact

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

bullet point

TissGeneSummary

bullet point

TissGeneExp

bullet point

TissGene-miRNA

bullet point

TissGeneMut: TissGeneSNV, TissGeneCNV, and TissGeneFusions

bullet point

TissGeneNet

bullet point

TissGeneProg

bullet point

TissGeneClin: TissGeneDrug and TissGeneDisease

TissGeneSummary for TFR2
check button Gene summary
Basic gene informationGene symbolTFR2
Gene nametransferrin receptor 2
SynonymsHFE3|TFRC2
CytomapUCSC genome browser: 7q22
Type of geneprotein-coding
RefGenesNM_001206855.1,
NM_003227.3,
Descriptiontransferrin receptor protein 2
Modification date20141222
dbXrefs MIM : 604720
HGNC : HGNC
Ensembl : ENSG00000106327
HPRD : 05282
Vega : OTTHUMG00000159598
ProteinUniProt:
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_TFR2
BioGPS: 7036
PathwayNCI Pathway Interaction Database: TFR2
KEGG: TFR2
REACTOME: TFR2
Pathway Commons: TFR2
ContextiHOP: TFR2
ligand binding site mutation search in PubMed: TFR2
UCL Cancer Institute: TFR2
Assigned class in TissGDB*A
Included tissue-specific gene expression resourcesHPA,TiGER,GTEx
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx)Liver
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA)LIHC
Reference showing the relevant tissue of TFR2Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2214-9. (pmid:10681454)
go to article
Description by TissGene annotations
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C.

check button Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO termPubMed ID


Top
TissGeneExp for TFR2

check button Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
gene exp


check button Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01)
gene isoform exp


check button Gene expressions across normal tissues of GTEx data
(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct)
- Here, we shows the matched tissue types only among our 28 cancer types.
normal gene exp


check button Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
DEG exp

- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05)
Cancer typeMean(exp) in tumorMean(exp) in matched normalLog2FCP-val.FDR
KIRC-1.240262323-3.5915748232.35131251.82E-138.21E-13
BRCA-0.189499165-2.74551322.5560140356.23E-287.16E-27
LUSC0.611002383-2.2905682052.9015705885.81E-206.81E-19
LUAD0.124750321-2.5288789892.653629319.43E-275.57E-25
KIRP-1.801475864-3.7610446141.959568751.03E-065.27E-06
COAD1.438355626-1.8522097593.2905653851.25E-123.30E-11
LIHC8.71525101110.15549301-1.4402428.37E-050.000293214
BLCA0.783881537-1.7103184632.49421.73E-050.000289287


Top
TissGene-miRNA for TFR2

check button Significantly anti-correlated miRNAs of TissGene across 28 cancer types
(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016)
(TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21)
(TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16)
(Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25))
Cancer typemiRNA idmiRNA accessionP-val.Coeff.# samples
LUADhsa-let-7a-5pMIMAT00000620.037-0.2760
LUADhsa-let-7b-5pMIMAT00000630.024-0.2960


Top
TissGeneMut for TFR2
TissGeneSNV for TFR2

check button nsSNV counts per each loci.
Different colors of circles represent different cancer types. Circle size denotes number of samples.
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)

* Click on the image to enlarge it in a new window.
SNV lollipop
bullet point


check button Somatic nucleotide variants of TissGene across 28 cancer types
(X-axis: cancer type and Y-axis: % of mutated samples)
The numbers in parentheses are numbers of samples with mutation (nsSNVs).
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
SNV distribution

- nsSNVs sorted by frequency.
AAchangeCancer type# samples
p.S360RLUAD1
p.T406AUCEC1
p.G100SSKCM1
p.T285AUCEC1
p.R30QESCA1
p.T575MCOAD1
p.H131YSKCM1
p.T782MCOAD1
p.R329WLGG1
p.Y594*OV1
p.E584KSKCM1
p.L783PESCA1
p.P299SSKCM1
p.A789VLGG1
p.G321ESKCM1
p.R774HPRAD1
p.R730CSTAD1
p.S538YUCEC1
p.P393ALUAD1
p.A347EESCA1
p.D194NBLCA1
p.A110VPCPG1
p.A510TCOAD1
p.H425YSKCM1
p.S770CLUAD1
p.P393LSKCM1
p.P564STHYM1
p.M54ISKCM1
p.R152CESCA1
p.S443FUCEC1
p.D434YKIRC1
p.Q24XSKCM1
p.D663NREAD1
p.G294ECOAD1
p.A81TSTAD1
p.R3QKIRP1
p.G439ESKCM1
p.V622MUCEC1
p.E254*LUSC1
p.H390YSKCM1
p.G430ASARC1
p.R774HSARC1
p.G392DKIRP1
p.F335YSKCM1
p.W192*LGG1
p.F772LCESC1
p.S421*BLCA1
p.F585LLIHC1
p.G78ESKCM1
p.D726NOV1
p.F574YHNSC1
p.E452KSKCM1
p.R455WSTAD1
p.P208RTHCA1
p.E686KESCA1
p.P523HLUAD1
p.E55KSKCM1
p.P61ALUAD1
p.Q146HUCEC1
p.N463SLIHC1
p.P61LSKCM1


Top
TissGeneCNV for TFR2

check button Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)
(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16)
CNV


Top
TissGeneFusions for TFR2

check button Fusion genes including TissGene
(ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01)
DatabaseSrcCancer typeSampleFusion geneORF5'-gene BP3'-gene BP


Top
TissGeneNet for TFR2

check button Co-expressed gene networks based on protein-protein interaction data (CePIN)
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(PINA2 ppi data)
BRCA (tumor)BRCA (normal)
TFR2, SOCS3, MECP2, TF, HFE (tumor)TFR2, SOCS3, MECP2, TF, HFE (normal)
bullet pointbullet point
COAD (tumor)COAD (normal)
TFR2, SOCS3, MECP2, TF, HFE (tumor)TFR2, SOCS3, MECP2, TF, HFE (normal)
bullet pointbullet point
HNSC (tumor)HNSC (normal)
TFR2, SOCS3, MECP2, TF, HFE (tumor)TFR2, SOCS3, MECP2, TF, HFE (normal)
bullet pointbullet point
KICH (tumor)KICH (normal)
TFR2, SOCS3, MECP2, TF, HFE (tumor)TFR2, SOCS3, MECP2, TF, HFE (normal)
bullet pointbullet point
KIRC (tumor)KIRC (normal)
TFR2, SOCS3, MECP2, TF, HFE (tumor)TFR2, SOCS3, MECP2, TF, HFE (normal)
bullet pointbullet point
KIRP (tumor)KIRP (normal)
TFR2, SOCS3, MECP2, TF, HFE (tumor)TFR2, SOCS3, MECP2, TF, HFE (normal)
bullet pointbullet point
LIHC (tumor)LIHC (normal)
TFR2, SOCS3, MECP2, TF, HFE (tumor)TFR2, SOCS3, MECP2, TF, HFE (normal)
bullet pointbullet point
LUAD (tumor)LUAD (normal)
TFR2, SOCS3, MECP2, TF, HFE (tumor)TFR2, SOCS3, MECP2, TF, HFE (normal)
bullet pointbullet point
LUSC (tumor)LUSC (normal)
TFR2, SOCS3, MECP2, TF, HFE (tumor)TFR2, SOCS3, MECP2, TF, HFE (normal)
bullet pointbullet point
PRAD (tumor)PRAD (normal)
TFR2, SOCS3, MECP2, TF, HFE (tumor)TFR2, SOCS3, MECP2, TF, HFE (normal)
bullet pointbullet point
STAD (tumor)STAD (normal)
TFR2, SOCS3, MECP2, TF, HFE (tumor)TFR2, SOCS3, MECP2, TF, HFE (normal)
bullet pointbullet point
THCA (tumor)THCA (normal)
TFR2, SOCS3, MECP2, TF, HFE (tumor)TFR2, SOCS3, MECP2, TF, HFE (normal)
bullet pointbullet point


Top
TissGeneProg for TFR2

check button Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image to enlarge it in a new window.
survival 1

check button Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 2

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 3

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 4

Top
TissGeneClin for TFR2
TissGeneDrug for TFR2

check button Drug information targeting TissGene
(DrugBank Version 5.0.6, 2017-04-01)
DrugBank IDDrug nameDrug activityDrug typeDrug status


Top
TissGeneDisease for TFR2

check button Disease information associated with TissGene
(DisGeNet, 2016-06-01)
Disease IDDisease name# pubmedsSource
umls:C0018995Hemochromatosis46BeFree,CTD_human,GAD,LHGDN
umls:C0282193Iron Overload34BeFree,GAD,LHGDN
umls:C0392514Hereditary hemochromatosis20BeFree,CLINVAR
umls:C1858664HEMOCHROMATOSIS, TYPE 311BeFree,CLINVAR,CTD_human,MGD,ORPHANET,UNIPROT
umls:C0268060Juvenile hemochromatosis7BeFree,GAD
umls:C2239176Liver carcinoma6BeFree
umls:C0023903Liver neoplasms5BeFree
umls:C0023467Leukemia, Myelocytic, Acute3BeFree
umls:C0002871Anemia2BeFree
umls:C0023890Liver Cirrhosis2BeFree
umls:C0162566Porphyria Cutanea Tarda2BeFree,GAD
umls:C0240066Iron deficiency2BeFree
umls:C0242383Age related macular degeneration2BeFree
umls:C2827503HFE-Associated Hereditary Hemochromatosis2BeFree
umls:C0000786Spontaneous abortion1GAD
umls:C0003873Rheumatoid Arthritis1GAD
umls:C0004114Astrocytoma1BeFree
umls:C0005283beta Thalassemia1BeFree,CTD_human
umls:C0006142Malignant neoplasm of breast1GAD
umls:C0010674Cystic Fibrosis1GAD
umls:C0012715Iron Metabolism Disorders1GAD
umls:C0014800Hyperplasia erythroid1BeFree
umls:C0020538Hypertensive disease1GAD
umls:C0023418leukemia1BeFree
umls:C0023440Acute Erythroblastic Leukemia1BeFree
umls:C0023449Acute lymphocytic leukemia1BeFree
umls:C0023473Myeloid Leukemia, Chronic1BeFree
umls:C0023895Liver diseases1GAD
umls:C0033027Preleukemia1BeFree
umls:C0085576Iron-Refractory Iron Deficiency Anemia1BeFree
umls:C0085669Acute leukemia1BeFree
umls:C0162316Iron deficiency anemia1BeFree
umls:C0239946Fibrosis, Liver1BeFree
umls:C0268059Neonatal hemochromatosis1BeFree
umls:C0376358Malignant neoplasm of prostate1BeFree
umls:C0472767Beta thalassemia intermedia1BeFree
umls:C0518014Hematocrit level1GAD,GWASCAT
umls:C0524910Hepatitis C, Chronic1GAD
umls:C0600139Prostate carcinoma1BeFree
umls:C1961102Precursor Cell Lymphoblastic Leukemia Lymphoma1BeFree
umls:C3463824MYELODYSPLASTIC SYNDROME1BeFree